Literature DB >> 10523596

Recovery of mycobacteria from patients with cystic fibrosis.

F C Bange1, P Kirschner, E C Böttger.   

Abstract

Despite decontamination, overgrowth by pseudomonads renders cultural isolation of mycobacteria from respiratory specimens of patients with cystic fibrosis (CF) difficult or impossible. We performed a prospective study by comparing levels of reduction of overgrowth and recovery of mycobacteria using either pretreatment with N-acetyl-L-cysteine (NALC)-NaOH alone or pretreatment with NALC-NaOH and then with oxalic acid. From 406 specimens of 148 CF patients, 11 specimens were positive for mycobacteria, 5 of which grew mycobacteria after decontamination by either procedure. Three specimens grew mycobacteria only after decontamination with NALC-NaOH, whereas three specimens grew mycobacteria only after treatment with NALC-NaOH followed by oxalic acid but were overgrown after decontamination with NALC-NaOH. Thus, inactivation of mycobacteria by the more aggressive oxalic acid treatment offsets its beneficial effect of reducing the proportion of cultures overgrown with microorganisms other than mycobacteria.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10523596      PMCID: PMC85755     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  8 in total

1.  Proficiency testing of clinical microbiology laboratories using modified decontamination procedures for detection of nontuberculous mycobacteria in sputum samples from cystic fibrosis patients. The Nontuberculous Mycobacteria in Cystic Fibrosis Study Group.

Authors:  S Whittier; K Olivier; P Gilligan; M Knowles; P Della-Latta
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

2.  Genotypic identification of mycobacteria by nucleic acid sequence determination: report of a 2-year experience in a clinical laboratory.

Authors:  P Kirschner; B Springer; U Vogel; A Meier; A Wrede; M Kiekenbeck; F C Bange; E C Böttger
Journal:  J Clin Microbiol       Date:  1993-11       Impact factor: 5.948

3.  Isolation of rapidly growing mycobacteria in patients with cystic fibrosis.

Authors:  B Boxerbaum
Journal:  J Pediatr       Date:  1980-04       Impact factor: 4.406

4.  Prospective study of mycobacterial infections in patients with cystic fibrosis.

Authors:  L Hjelte; B Petrini; G Källenius; B Strandvik
Journal:  Thorax       Date:  1990-05       Impact factor: 9.139

5.  Nontuberculous mycobacteria in adult patients with cystic fibrosis.

Authors:  J M Kilby; P H Gilligan; J R Yankaskas; W E Highsmith; L J Edwards; M R Knowles
Journal:  Chest       Date:  1992-07       Impact factor: 9.410

6.  Clinical features of pulmonary disease caused by rapidly growing mycobacteria. An analysis of 154 patients.

Authors:  D E Griffith; W M Girard; R J Wallace
Journal:  Am Rev Respir Dis       Date:  1993-05

7.  Improved recovery of mycobacteria from respiratory secretions of patients with cystic fibrosis.

Authors:  S Whittier; R L Hopfer; M R Knowles; P H Gilligan
Journal:  J Clin Microbiol       Date:  1993-04       Impact factor: 5.948

8.  Nontuberculous mycobacterial disease in adult cystic fibrosis patients.

Authors:  M L Aitken; W Burke; G McDonald; C Wallis; B Ramsey; C Nolan
Journal:  Chest       Date:  1993-04       Impact factor: 9.410

  8 in total
  22 in total

Review 1.  Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.

Authors:  Barbara A Brown-Elliott; Kevin A Nash; Richard J Wallace
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

2.  Value of the chlorhexidine decontamination method for recovery of nontuberculous mycobacteria from sputum samples of patients with cystic fibrosis.

Authors:  Agnès Ferroni; Hoang Vu-Thien; Philippe Lanotte; Muriel Le Bourgeois; Isabelle Sermet-Gaudelus; Brigitte Fauroux; Sophie Marchand; Françoise Varaigne; Patrick Berche; Jean-Louis Gaillard; Catherine Offredo
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

3.  Fatal pulmonary infection due to multidrug-resistant Mycobacterium abscessus in a patient with cystic fibrosis.

Authors:  M Sanguinetti; F Ardito; E Fiscarelli; M La Sorda ; P D'Argenio; G Ricciotti; G Fadda
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

4.  Intra- and interpatient variability of the hsp65 and 16S-23S intergenic gene region in Mycobacterium abscessus strains from patients with cystic fibrosis.

Authors:  Brigitte König; Ina Tammer; Veronika Sollich; Wolfgang König
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

5.  Non-tuberculous mycobacteria in end stage cystic fibrosis: implications for lung transplantation.

Authors:  W Chalermskulrat; N Sood; I P Neuringer; T M Hecker; L Chang; M P Rivera; L J Paradowski; R M Aris
Journal:  Thorax       Date:  2006-04-06       Impact factor: 9.139

6.  Sampling and decontamination method for culture of nontuberculous mycobacteria in respiratory samples of cystic fibrosis patients.

Authors:  Annelies De Bel; Deborah De Geyter; Iris De Schutter; Christine Mouton; Isabelle Wellemans; Laurence Hanssens; Petra Schelstraete; Anne Malfroot; Denis Pierard
Journal:  J Clin Microbiol       Date:  2013-09-18       Impact factor: 5.948

7.  LightCycler-based differentiation of Mycobacterium abscessus and Mycobacterium chelonae.

Authors:  L Sedlacek; M Rifai; K Feldmann; F C Bange
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

8.  Rapid-cycle PCR and fluorimetry for detection of mycobacteria.

Authors:  Jacqueline Lachnik; Birgit Ackermann; Antje Bohrssen; Silvia Maass; Catharina Diephaus; Axel Puncken; Marion Stermann; Franz-Christoph Bange
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

9.  Characterization of rough and smooth morphotypes of Mycobacterium abscessus isolates from clinical specimens.

Authors:  Kai Rüger; Annegret Hampel; Sandra Billig; Nadine Rücker; Sebastian Suerbaum; Franz-Christoph Bange
Journal:  J Clin Microbiol       Date:  2013-11-06       Impact factor: 5.948

10.  Epidemiology of nontuberculous mycobacterial infections and associated chronic macrolide use among persons with cystic fibrosis.

Authors:  Alison M Binder; Jennifer Adjemian; Kenneth N Olivier; D Rebecca Prevots
Journal:  Am J Respir Crit Care Med       Date:  2013-10-01       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.